Effectiveness, tolerability and safety of opicapone in fluctuating Parkinson's disease

被引：0
|
作者：
Marti-Andres, G. [1 ]
Armengou, L. [1 ]
Esparragosa, I. [1 ]
Toledano Illan, C. [1 ]
Valenti, R. [1 ]
Luquin, R. [1 ]
机构：
[1] Clin Univ Navarra, Neurol, Pamplona, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1184
引用
收藏
页码：633 / 634
页数：2
相关论文
共 50 条
  • [1] Safety and Tolerability of opicapone in Parkinson's disease
    Campins Romeu, M.
    Losada Lopez, M.
    Sastre Bataller, I.
    Perez Garcia, M. J.
    Martinez Torres, I.
    MOVEMENT DISORDERS, 2019, 34 : S326 - S326
  • [2] Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease
    Ferreira, Joaquim J.
    Lees, Andrew J.
    Poewe, Werner
    Rascol, Olivier
    Rocha, Jose-Francisco
    Keller, Birgit
    Soares-da-Silva, Patricio
    NEUROLOGY, 2018, 90 (21) : E1849 - E1857
  • [3] Opicapone in fluctuating Parkinson's disease: The daily clinical practice
    Armengou Garcia, L.
    Marti-Andres, G.
    Valenti Azcarate, R.
    Esparragosa Vazquez, I.
    Toledano Illan, C.
    Villino Boquete, R.
    Luquin, R.
    MOVEMENT DISORDERS, 2020, 35 : S436 - S437
  • [4] Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
    Ferreira, Joaquim J.
    Poewe, Werner
    Rascol, Olivier
    Stocchi, Fabrizio
    Antonini, Angelo
    Moreira, Joana
    Guimaraes, Bruno
    Rocha, Jose-Francisco
    Soares-da-Silva, Patricio
    MOVEMENT DISORDERS, 2022, 37 (11) : 2272 - 2283
  • [5] Safety Profile of Opicapone in the Management of Parkinson's Disease
    Lees, Andrew
    Ferreira, Joaquim J.
    Rocha, Jose-Francisco
    Rascol, Olivier
    Poewe, Werner
    Gama, Helena
    Soares-da-Silva, Patricio
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (04) : 733 - 740
  • [6] Hepatic safety of opicapone in Parkinson's disease patients
    Lopes, N.
    Ferreira, J.
    Lees, A.
    Gama, H.
    Santos, A.
    Oliveira, C.
    Costa, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S101 - S101
  • [7] Efficacy and tolerability of opicapone in Parkinson's disease in usual clinical practice
    Gomez-Mayordomo, V.
    Alonso-Frech, F.
    Lopez-Valdes, E.
    Garcia-Ramos, R.
    Catalan-Alonso, M.
    MOVEMENT DISORDERS, 2020, 35 : S450 - S450
  • [8] Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease
    Schofield, Christine
    Chaudhuri, K. Ray
    Carroll, Camille
    Sharma, Jagdish C.
    Pavese, Nicola
    Evans, Jonathan
    Foltynie, Thomas
    Reichmann, Heinz
    Zurowska, Laura
    Soares-da-Silva, Patricio
    Lees, Andrew
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2022, 12 (02) : 77 - 91
  • [9] Evaluation of hepatic safety of opicapone in patients with Parkinson's disease
    Lopes, N.
    Ferreira, J.
    Lees, A.
    Gama, H.
    Santos, A.
    Oliveira, C.
    Costa, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 439 - 439
  • [10] Safety and tolerability of opicapone in the treatment of Parkinson's disease and motor fluctuations: Analysis of pooled phase III studies
    Ferreira, J.
    Lees, A.
    Gama, H.
    Lopes, N.
    Santos, A.
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S86 - S86
12345